Actualités Decode Genetics (MM) - DCGN | Actions NASDAQ | ADVFN

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Decode Genetics (MM) (DCGN)
Decode Genetics (MM) (DCGN) Actualités

Decode Genetics (MM) (DCGN)

0,0718

0,00

(0,00%)

Fermé 17 Février 10:00PM

Retardé de 15 minutes

0,00

0,00

(0,00%)

Après les heures de négociation: -

Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

deCODE Discovers Genetic Risk Factor for Sick Sinus Syndrome

deCODE Discovers Genetic Risk Factor for Sick Sinus Syndrome PR Newswire REYKJAVIK, Iceland, March 6, 2011 REYKJAVIK, Iceland, March 6, 2011...

Announcing the New deCODE

REYKJAVIK, Iceland, January 21 /PRNewswire-FirstCall/ -- deCODE genetics ehf today emerged as a newly financed, private company focused on...

deCODE Finds Genetic Factors Impacting Key Clinical Measurements of Heart Activity and Disease Risk

REYKJAVIK, Iceland, January 10 /PRNewswire-FirstCall/ -- - Novel SNPs Modulate ECG Measurements Including Heart Rate, Two are Also Risk Factors...

deCODE Receives Trading Suspension and Delisting Notice From Nasdaq

REYKJAVIK, Iceland, January 5 /PRNewswire-FirstCall/ -- deCODE genetics, Inc. (NASDAQ:DCGN) today announced that it has received notice from the...

deCODE Receives Nasdaq Deficiency Notice

REYKJAVIK, Iceland, December 30 /PRNewswire-FirstCall/ -- deCODE genetics, Inc. (NASDAQ:DCGN) today announced that it has received a notice from...

- Current report filing (8-K)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT...

- Current report filing (8-K)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT...

deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin

A Single SNP That Confers Increased Risk if Inherited From the Father, but is Protective if Inherited From the Mother REYKJAVIK, Iceland...

- Current report filing (8-K)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT...

deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal

REYKJAVIK, Iceland, November 24 /PRNewswire-FirstCall/ -- deCODE genetics, Inc. (NASDAQ:DCGN) today announced that it has received notice from...

deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court

Iceland-Based Subsidiary to Use Debtor-in-Possession Financing to Continue Genetics Operations and Offer All Product and Service Lines During...

- Current report filing (8-K)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT...

deCODE genetics, Inc. Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets

Enters into asset purchase agreement and receives commitment for debtor-in-possession financing to continue operations during Chapter 11 process...

- Notification that Quarterly Report will be submitted late (NT 10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE...

- Current report filing (8-K)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

National Beverage

HSBC MSCI China A UCITS ...

Bnp Paribas Issuance

Jefferson Bancshares

VIRGIN AMERICA INC.

Nasdaq Bio Tech

Brisanet Participacoes ON

Lyxor Asset Management L...

WiseTech Global

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales